Gallop meeting on November 19th: Cabio Biotech(Wuhan) (688089.SH) stated on the interactive platform that, regarding the application of artificial intelligence in research and development, the company has explored the fields of synthetic biology and artificial intelligence. Currently, it has a small AIGC that can be fine-tuned through training. It can be specifically applied to organizing experimental reports, initial design of technical solutions, construction of literature knowledge graphs, and monitoring of product information markets. This helps improve the efficiency and quality of research and development, promotes the intelligence and automation of scientific research work, and provides strong intellectual support for R&D activities.